Ac-Gly-OH

Catalog No.: 
ACXLVB851
CAS No.: 
543-24-8
Molecular Formula: 
C4H7NO3
Molecular Weight: 
117.10
Ac-Gly-OH structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g98%$63.00In stockInquiry
1000g98%$105.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAc-Gly-OH
IUPAC Nameacetylglycine
MDL No.MFCD00004275
Molecular FormulaC4H7NO3
Molecular Weight117.10
SMILESCC(=O)NCC(O)=O
InChI KeyOKJIRPAQVSHGFK-UHFFFAOYSA-N
SynonymAc-Gly-OH | acetamidoacetate | ACETURIC ACID [MI] | bmse000610 | DB02713 | F0921-6976 | N-Acetylglycine, Vetec(TM) reagent grade, 98% | 2-acetamidoacetate | MFCD00004275 | U2UT4677KR | CS-W020121 | EU-0096429 | BDBM82197 | EINECS 208-839-6 | NSC7605 | NSC-7605 | Ac Gly | A0093 | Acetyl Glyc
CAS No.543-24-8
PubChem CID10972

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACXLVB851 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEUXN150 route compound structure diagram
    ACEUXN150475473-26-8In Stock
  4. Then
  5. ACXLVB851 route product structure diagram
    ACXLVB851543-24-8In Stock
Inquiry

2. ACXLVB851 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEUXN150 route compound structure diagram
    ACEUXN150475473-26-8In Stock
  4. Then
  5. ACXLVB851 route product structure diagram
    ACXLVB851543-24-8In Stock
Inquiry

3. ACXLVB851 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZVMD307 route compound structure diagram
    ACZVMD3071906-82-7In Stock
  2. Then
  3. ACXLVB851 route product structure diagram
    ACXLVB851543-24-8In Stock
Inquiry

Comments (0)